project id: TCGA-PAAD; case submitter id: TCGA-M8-A5N4; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 7.6; age at index: 48; days to birth: -17628; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; age at diagnosis: 17628; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 584.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-M8-A5N4-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 5.0; percent necrosis: 20.0; percent neutrophil infiltration: 12.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 25.0; percent tumor nuclei: 65.0;